Announcements Trials

Browse Landscape

Phase

Status

Recruiting 12 Completed 12 Active not recruiting 7 Unknown 4 Terminated 3 Not yet recruiting 3 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 240 Carcinoma, Renal Cell 75 Urinary Bladder Neoplasms 56 Kidney Neoplasms 32 Breast Neoplasms 26 Neoplasms 25 Carcinoma, Transitional Cell 22 Neoplasm Metastasis 21 Carcinoma, Non-Small-Cell Lung 14 Sarcoma 11 Non-Muscle Invasive Bladder Neoplasms 11 Lung Neoplasms 11 Melanoma 10 Wilms Tumor 8 Testicular Neoplasms 8 Colorectal Neoplasms 8 Uterine Cervical Neoplasms 7 Urologic Neoplasms 7 Stomach Neoplasms 7 Pancreatic Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Small Cell Lung Carcinoma 6 Recurrence 6 Ovarian Neoplasms 6 Endometrial Neoplasms 6 Carcinoma, Hepatocellular 6 Carcinoma 6 Prostatic Neoplasms, Castration-Resistant 5 Neuroblastoma 5 Esophageal Neoplasms 5

Interventions

atezolizumab 1 PROSTVAC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostate Adenocarcinoma × Genitourinary × Clear all

NCT04020094 2021-09-22

AtezoVax

University of Utah

Phase 2 Withdrawn

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡